BioIntelliSense Named “2023 Best Overall Medical Device Company” in 7th Annual MedTech Breakthrough Awards Program
03 mai 2023 16h11 HE
|
BioIntellisense, Inc.
DENVER, May 03, 2023 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, has been recognized as the “Best Overall Medical Device Company” for 2023...
BioIntelliSense and care.ai Announce Partnership to Leverage Continuous Biometric Data and Ambient Intelligent Monitoring to Improve the Delivery of Patient Care
10 janv. 2023 07h00 HE
|
BioIntellisense, Inc.
BioIntelliSense’s FDA-cleared BioButton® wearable devices and advanced data analytics will integrate with care.ai’s AI-powered Smart Care Facility Platform™ to streamline clinical workflows and...
BioIntelliSense named CES 2023 Innovation Award Honoree for its BioButton® continuous monitoring and clinical intelligence solutions for in-hospital to home
05 janv. 2023 16h33 HE
|
BioIntellisense, Inc.
DENVER, Jan. 05, 2023 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, has been named a CES® 2023 Innovation Awards Honoree for its BioButton®...
BioIntelliSense and Medically Home Announce Strategic Collaboration to Enhance Patient Management for High Acuity Hospital Care at Home
10 nov. 2022 07h00 HE
|
BioIntellisense, Inc.
DENVER, Nov. 10, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced it has entered into a strategic partnership with...
BioIntelliSense Launches Patented, FDA-cleared Pulse Oximetry (SpO2) Sensor Technology that Addresses Skin Pigmentation and Motion Monitoring Challenges
01 nov. 2022 07h00 HE
|
BioIntellisense, Inc.
Breakthrough pulse oximetry (SpO2) optical sensor solution offers medical-grade accuracy of oxygen level measurement across skin tones and while in motionPatented SpO2 sensor chipset, integrated...
Houston Methodist and BioIntelliSense Announce Strategic Collaboration to Advance New Remote Care and Clinical Intelligence Solutions
02 mai 2022 07h30 HE
|
BioIntellisense, Inc.
HOUSTON and DENVER, May 02, 2022 (GLOBE NEWSWIRE) -- Houston Methodist and Colorado-based BioIntelliSense, a continuous health monitoring and clinical intelligence company, today announced a new...
UC Davis Health and BioIntelliSense Form Strategic Collaboration to Advance Continuous Remote Care Models for In-Hospital to Home Monitoring
02 mai 2022 07h00 HE
|
BioIntellisense, Inc.
SACRAMENTO, Calif. and DENVER, May 02, 2022 (GLOBE NEWSWIRE) -- California-based UC Davis Health and Colorado-based BioIntelliSense, a continuous health monitoring and clinical intelligence company,...
UPDATE – BioIntelliSense Launches New BioButton® Rechargeable Wearable Device for Continuous Medical Grade Monitoring of 20+ Vital Signs and Biometrics
15 mars 2022 12h54 HE
|
Biointellisense, Inc.
DENVER, March 15, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, expands its commitment to creating a new standard of remote patient...
BioIntelliSense Launches New BioButton® Rechargeable Wearable Device for Continuous Medical Grade Monitoring of 20+ Vital Signs and Biometrics
15 mars 2022 08h00 HE
|
Biointellisense, Inc.
DENVER, March 15, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, a continuous health monitoring and clinical intelligence company, expands its commitment to creating a new standard of remote patient care...
BioIntelliSense and UAE-based Mubadala Health Establish Strategic Collaboration to Enable Continuous Care Model for Medical Grade Remote Monitoring and Management
02 mars 2022 07h00 HE
|
Biointellisense, Inc.
DENVER and ABU DHABI, United Arab Emirates, March 02, 2022 (GLOBE NEWSWIRE) -- BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, announced today its strategic...